Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection
Authors:
- R S SmithRSR S Smith
- R B NasoRNR B Naso
- J RosenJRJ Rosen
- A WhalleyAWA Whalley
- Y L HomYHY L Hom
- K HoeyKHK Hoey
- C J KennedyCKC J Kennedy
- J A McCutchanJMJ A McCutchan
- S A SpectorSSS A Spector
- D D RichmanDRD D Richman
- 1 August 1987
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 25 (8) , 1498-1504
Abstract
Detection of antibodies to human immunodeficiency virus (HIV) by enzyme-linked immunosorbent assay (ELISA) is the accepted method to screen blood products at risk to transmit infection. The presence of antibodies to HIV in 565 serum specimens from 274 patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex, symptomatic and asymptomatic subjects at risk for AIDS, and controls was determined with an ELISA that incorporates synthetic peptides (designated E32/E34) representing sequences in the envelope glycoprotein gp41. Of 105 specimens from patients with AIDS or AIDS-related complex, 3 specimens that were negative by commercially licensed ELISA and immunoblot test were similarly unreactive in the E32/E34 ELISA. For homosexual men with generalized lymphadenopathy, 186 specimens were positive by the E32/E34 ELISA and 63 specimens were negative. In comparison, with the licensed ELISA, 184 of these samples were positive and 65 samples were negative. The two samples that were positive in the E32/E34 ELISA but not the commercial kit were also positive by immunoblotting. Sequential sera from one individual who apparently underwent seroconversion according to the commercial assays were all positive by E32/E34 ELISA and immunoblotting. Thus, the ELISA with synthetic peptides is an extremely sensitive and specific test of antibody response to HIV and has not yet yielded a negative result with a Western blot (immunoblot)-confirmed antibody-positive serum.Keywords
This publication has 26 references indexed in Scilit:
- Antiserum to a Synthetic Peptide Recognizes the HTLV-III Envelope GlycoproteinScience, 1986
- Asymptomatic Blood Donor with a False Positive HTLV-III Western BlotNew England Journal of Medicine, 1986
- Screening Donated Blood and Plasma for HTLV-III AntibodyNew England Journal of Medicine, 1985
- The AIDS EpidemicNew England Journal of Medicine, 1985
- Antibodies to HTLV-III in Swiss Patients with AIDS and Pre-AIDS and in Groups at Risk for AIDSNew England Journal of Medicine, 1985
- HTLV-III testing of donor blood imminent; complex issues remain1985
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDSScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983